GlassScriptPhysician profile
Rose Nkolika Ezeani
NPI 1609921568
$6,005.98
in general payments reported to CMS, 2019-2025
24 companies · $1,102 in 2025
The $1,102 reported for 2025 was more than what 86% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $73.40 · 2022: $1,571 · 2023: $1,359 · 2024: $1,901 · 2025: $1,102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,361.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,683.88 | 2022-2025 | |
| Abbott Laboratories | $711.93 | 2021-2025 | Freestyle Libre 3, Freestyle Libre Pro |
| Astrazeneca Pharmaceuticals LP | $496.77 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $443.09 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Amgen INC. | $373.28 | 2022-2025 | Repatha, Otezla, Otezla |
| Glaxosmithkline, LLC. | $314.21 | 2023-2025 | Trelegy Ellipta, Arexvy |
| Merck Sharp & Dohme LLC | $296.25 | 2024-2025 | Verquvo, Gardasil 9, Capvaxive |
| Otsuka America Pharmaceutical, INC. | $236.76 | 2023-2024 | Rexulti |
| Lilly USA, LLC | $191.97 | 2022-2025 | Jardiance, Mounjaro, Emgality |
| Exact Sciences Corporation | $152.41 | 2023-2025 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $148.17 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $144.40 | 2022 | |
| Esperion Therapeutics, INC. | $124.58 | 2022 | |
| Genentech USA, INC. | $121.65 | 2024 | Xolair |
| Pfizer INC. | $104.17 | 2021-2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $93.17 | 2024-2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $83.49 | 2022 | |
| Neurelis, INC. | $81.03 | 2024 | Valtoco |
| Amarin Pharma, INC. | $76.38 | 2022 | |
| Inspire Medical Systems, INC. | $37.83 | 2024 | Inspire |
| Boston Scientific Corporation | $29.06 | 2025 | Watchman Flx |
| Daiichi Sankyo INC. | $24.55 | 2022 | |
| Dexcom, INC. | $22.59 | 2023 | Dexcom G6 Transmitter |
| Evoke Pharma, INC. | $14.36 | 2023 | Gimoti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rose Ezeani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.